Chronogen Inc.
Chronogen is a privately held drug discovery company developing drugs to treat age-dependent diseases, with a focus on oxidative stress in cardiovascular diseases, inflammation, CNS diseases and cancer. Using a suite of technologies including genetics, in vivo screening, and computational chemistry, the company discovers metabolic pathways that affect age-dependent diseases, and identifies points along those pathways that are ideally suited for drug intervention.
http://www.chronogen-inc.com/
